Search Results - "Hu, Quanyin"
-
1
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook
Published in Advanced materials (Weinheim) (01-08-2017)“…Cancer immunotherapy, as a paradigm shift in cancer treatment, has recently received tremendous attention. The active cancer vaccination, immune checkpoint…”
Get full text
Journal Article -
2
Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment
Published in Nature communications (06-04-2022)“…Immunosuppressive cells residing in the tumor microenvironment, especially tumor associated macrophages (TAMs), hinder the infiltration and activation of T…”
Get full text
Journal Article -
3
Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation
Published in Chemical Society reviews (04-07-2022)“…Proteolysis Targeting Chimeras (PROTACs), an emerging therapeutic entity designed to degrade target proteins by hijacking the ubiquitin-proteasome system, have…”
Get more information
Journal Article -
4
Recent advances in overcoming barriers to cell‐based delivery systems for cancer immunotherapy
Published in Exploration (Beijing, China) (01-06-2022)“…Immunotherapy strategies that use cell‐based delivery systems have sparked much interest in the treatment of malignancies, owing to their high…”
Get full text
Journal Article -
5
Anticancer Platelet-Mimicking Nanovehicles
Published in Advanced materials (Weinheim) (25-11-2015)“…A core–shell nanovehicle coated with a platelet membrane (PM) is developed for targeted and site‐specific delivery of an extracellularly active drug and an…”
Get full text
Journal Article -
6
Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR-Cas9 for Genome Editing
Published in Angewandte Chemie International Edition (05-10-2015)“…CRISPR–Cas9 represents a promising platform for genome editing, yet means for its safe and efficient delivery remain to be fully realized. A novel vehicle that…”
Get full text
Journal Article -
7
Sequentially Site-Specific Delivery of Thrombolytics and Neuroprotectant for Enhanced Treatment of Ischemic Stroke
Published in ACS nano (27-08-2019)“…Ischemic stroke caused by a thrombus clog and ischemia is one of the most lethal and disabling cerebrovascular diseases. A sequentially targeted delivery…”
Get full text
Journal Article -
8
Shape-controlled synthesis of liquid metal nanodroplets for photothermal therapy
Published in Nano research (01-06-2019)“…The capping agents for liquid metal (LM) nanodroplets in aqueous solutions are restricted to thiol-containing and positively-charged molecules or…”
Get full text
Journal Article -
9
Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy
Published in Advanced materials (Weinheim) (01-05-2016)“…A light‐activated hypoxia‐responsive conjugated polymer‐based nanocarrier is developed for efficiently producing singlet oxygen (1O2) and inducing hypoxia to…”
Get full text
Journal Article -
10
Enhancing Gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response
Published in Nature communications (24-10-2022)“…Pore-forming Gasdermin protein-induced pyroptosis in tumor cells promotes anti-tumor immune response through the release of pro-inflammatory cytokines and…”
Get full text
Journal Article -
11
PD‐1 Blockade Cellular Vesicles for Cancer Immunotherapy
Published in Advanced materials (Weinheim) (01-05-2018)“…Cancer cells resist to the host immune antitumor response via multiple suppressive mechanisms, including the overexpression of PD‐L1 that exhausts…”
Get full text
Journal Article -
12
Transformable liquid-metal nanomedicine
Published in Nature communications (02-12-2015)“…To date, numerous inorganic nanocarriers have been explored for drug delivery systems (DDSs). However, the clinical application of inorganic formulations has…”
Get full text
Journal Article -
13
In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
Published in Nature biomedical engineering (01-02-2017)“…Cancer recurrence after surgical resection remains a significant challenge in cancer therapy. Platelets, which accumulate in wound sites and interact with…”
Get full text
Journal Article -
14
Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets
Published in Nature biomedical engineering (01-09-2021)“…The immunosuppressive microenvironment of solid tumours reduces the antitumour activity of chimeric antigen receptor T cells (CAR-T cells). Here, we show that…”
Get full text
Journal Article -
15
Chiral Supraparticles for Controllable Nanomedicine
Published in Advanced materials (Weinheim) (01-01-2020)“…Chirality is ubiquitous in nature and hard‐wired into every biological system. Despite the prevalence of chirality in biological systems, controlling…”
Get full text
Journal Article -
16
Convergence of nanomedicine and neutrophils for drug delivery
Published in Bioactive materials (01-05-2024)“…Neutrophils have recently emerged as promising carriers for drug delivery due to their unique properties including rapid response toward inflammation,…”
Get full text
Journal Article -
17
Anaerobe‐Inspired Anticancer Nanovesicles
Published in Angewandte Chemie International Edition (01-03-2017)“…Anaerobic bacteria, such as Clostridium and Salmonella, can selectively invade and colonize in tumor hypoxic regions (THRs) and deliver therapeutic products to…”
Get full text
Journal Article -
18
Bio‐Orthogonal Chemistry in Cell Engineering
Published in Advanced NanoBiomed Research (Online) (01-03-2023)“…Cell therapy holds great promise in addressing a wide range of malignant diseases, such as cancers and infectious diseases. The convergence of chemistry,…”
Get full text
Journal Article -
19
Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy
Published in Nature biomedical engineering (01-11-2018)“…Patients with acute myeloid leukaemia who relapse following therapy have few treatment options and face poor outcomes. Immune checkpoint inhibition, for…”
Get full text
Journal Article -
20
Dual targeted nanocarrier for brain ischemic stroke treatment
Published in Journal of controlled release (10-07-2016)“…Focal cerebral ischemia, known as stroke, causes serious long-term disabilities globally. Effective therapy for cerebral ischemia demands a carrier that can…”
Get full text
Journal Article